Ocular tuberculosis : Where are we today?

Diagnosis and management of ocular tuberculosis (OTB) poses a significant challenge. Mixed ocular tissue involvement and lack of agreement on best practice diagnostic tests together with the global variations in therapeutic management contributed to the existing uncertainties regarding the outcome of the disease. The current review aims to update recent progress on OTB. In particular, the Collaborative Ocular Tuberculosis Study (COTS) group recently standardized a nomenclature system for defining clinical phenotypes, and also proposed consensus guidelines and an algorithmic approach for management of different clinical phenotypes of OTB. Recent developments in experimental research and innovations in molecular diagnostics and imaging technology have provided a new understanding in the pathogenesis and natural history of the disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:68

Enthalten in:

Indian journal of ophthalmology - 68(2020), 9 vom: 20. Sept., Seite 1808-1817

Sprache:

Englisch

Beteiligte Personen:

Testi, Ilaria [VerfasserIn]
Agrawal, Rupesh [VerfasserIn]
Mehta, Salil [VerfasserIn]
Basu, Soumvaya [VerfasserIn]
Nguyen, Quan [VerfasserIn]
Pavesio, Carlos [VerfasserIn]
Gupta, Vishali [VerfasserIn]

Links:

Volltext

Themen:

Antitubercular Agents
Antitubercular therapy
COTS CON nomenclature
Collaborative ocular tuberculosis study (COTS)
Etiopathogenesis
Journal Article
Multimodal imaging
Ocular tuberculosis
Review
Tubercular uveitis

Anmerkungen:

Date Completed 14.05.2021

Date Revised 30.03.2024

published: Print

Citation Status MEDLINE

doi:

10.4103/ijo.IJO_1451_20

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM313971277